menu
    • menu

    Company profile for Ventus Therapeutics

    NEW Drugs in Dev: 4
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. We are uniquely enabled by our field-leading structural immunology platform, a highly experienced management and drug discovery team that has delivered multiple marketed compounds, and leading academics spanning the fields of struc...
    At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. We are uniquely enabled by our field-leading structural immunology platform, a highly experienced management and drug discovery team that has delivered multiple marketed compounds, and leading academics spanning the fields of structural biology and immunology. Guided by a patient-centric ethos, our aim is to rapidly advance multiple drug candidates. Our emerging pipeline focuses on the inflammasome and nucleic acid sensing pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ventus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    21 Strathmore Rd. Natick, Massachusetts 01760
    Telephone
    Telephone
    514-397-9517
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ventustx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ventus Therapeutics Nominates VENT-04 as First-in-Class Candidate
    Ventus Therapeutics Nominates VENT-04 as First-in-Class Candidate

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106803008/en/Ventus-Therapeutics-Announces-Nomination-of-VENT-04-a-First-in-Class-Oral-Small-Molecule-Caspase-45-Inhibitor-as-a-Development-Candidate

    BUSINESSWIRE
    07 Jan 2026
    Share Share
    Ventus Launches Phase 2 Trial of VENT-03 cGAS Inhibitor in Lupus
    Ventus Launches Phase 2 Trial of VENT-03 cGAS Inhibitor in Lupus

    10 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209988664/en/Ventus-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-VENT-03-a-Novel-Small-Molecule-cGAS-Inhibitor-in-Patients-with-Lupus

    BUSINESSWIRE
    10 Dec 2025
    Share Share
    Ventus Pharma Collaborates With Genentech On Small-Molecule
    Ventus Pharma Collaborates With Genentech On Small-Molecule

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020110977/en/Ventus-Therapeutics-Enters-into-a-Collaboration-and-License-Agreement-with-Genentech-to-Discover-and-Develop-Small-Molecule-Medicines-Using-Ventus-ReSOLVE-Platform

    BUSINESSWIRE
    21 Oct 2025
    Share Share
    Ventus to Present at Morgan Stanley 23rd Annual Global Conference
    Ventus to Present at Morgan Stanley 23rd Annual Global Conference

    04 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903331638/en/Ventus-Therapeutics-to-Present-at-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference

    BUSINESSWIRE
    04 Sep 2025
    Share Share
    Ventus to Present Phase 1 Results for VENT-03 at LUPUS 2025
    Ventus to Present Phase 1 Results for VENT-03 at LUPUS 2025

    22 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250521929176/en/Ventus-Therapeutics-to-Present-Phase-1-Results-for-VENT-03-a-First-in-Class-cGAS-Inhibitor-at-LUPUS-2025

    BUSINESSWIRE
    22 May 2025
    Share Share
    Ventus Therapeutics to Present at 2025 Bloom Burton & Co. Conf
    Ventus Therapeutics to Present at 2025 Bloom Burton & Co. Conf

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425824044/en/Ventus-Therapeutics-to-Present-at-2025-Bloom-Burton-Co.-Healthcare-Investor-Conference

    BUSINESSWIRE
    29 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search